Tecan Group AG · SIX:TECN

Tecan — Mimetas — Technical Presentation (2023)

20 slides from Tecan's technical presentation, Apr 24, 2023

  1. Slide 1: Coupling organ-on-chip and multimode plate readers: snake venom toxicity

    Coupling organ-on-chip and multimode plate readers: Real-time assessment of snake venom toxicity on a three-dimensional blood vessel model Sebastiaan J. Trietsch

  2. Slide 2: Wrong model means wrong conclusions

    Wrong model means wrong conclusions Simple cell cultures & animal models fail to capture the complexity of human disease 2

  3. Slide 3: MIMETAS provides the right model

    MIMETAS provides the right model Human Organ-on-a-Chip technology recapitulates the human organ niche and captures the complexity of disease 3

  4. Slide 4: The right model looks like this…

    The right model looks like this… Epithelia Connective tissue Vasculature Immune system 4

  5. Slide 5: … yields robust and quantitative data

    … yields robust and quantitative data TEER measurement Immune cell Migration Angiogenesis Actin CD45 E-selectin/CD62E Nuclei 2CC Apical exposure 0 150 200 D is t a n c e ( in µ m ) relative to control % TEER ( cm2) 100 400 600 50 800 1000 0 1200 2h h h h 24 48 72 1 hour 24 h o u rs 48 h o u rs 5

  6. Slide 6: … and can be repeated thousands of times

    … and can be repeated thousands of times Screenable platform Automated workflow High content screening systems and multimode readers Thousands of chips 6

  7. Slide 7: Spark Cyto – live cell multimode plate reader with real-time image cytometry

    Spark® Cyto – live cell multimode plate reader with real-time image cytometry A POWERFUL TOOL FOR MULTIPLEXING Cell incubation with Intuitive and user- Absorbance with Fluorescence with Luminescence with Brightfield and Automate your friendly temperature/ gas high-speed FUSION Optics BRET & NanoBRET

  8. Slide 8: Spark Cyto imaging - key applications at a glance

    Spark Cyto imaging - key applications at a glance • Nuclei counting • Viability • Label-free cell counting • Apoptosis • Transfection efficiency Counting Multi-Color applications Confluence 8

  9. Slide 9: Synergy between OrganoPlate and Tecan Spark Cyto

    Synergy between OrganoPlate and Tecan Spark Cyto OrganoPlate Tecan Spark Cyto Ease of use Scalable and throughput capable Imaging capable 9

  10. Slide 10: Venomous snake bites affects millions

    Venomous snake bites affects millions Snakebite seriously injure up to 2.7 million people and claim some 125,000 lives. (World Health Organization) 10

  11. Slide 11: Toxicity of snake venoms

    Toxicity of snake venoms Damage to blood or blood vessels Circulatory system Internal bleeding and organ dysfunction Snake venom Damage to neurons and muscles Neuromuscular system Paralysis, respiratory failure, cardiac arrest Snake venoms are comprised of a complex cocktail of bioactive substances.

  12. Slide 12: Venom-induced vascular toxicity model

    Venom-induced vascular toxicity model Snake venom Four different venomous snake species Vascular leakage Morphology Viability Toxicity Collagen 1 HUVECs 12

  13. Slide 13: Integrated multiplex workflow

    Integrated multiplex workflow • One integrated workflow protocol • Multiplexed fluorescence intensity measurements and imaging • Temperature controlled environment Snake venom Cell incubation with Intuitive and user- temperature/ gas friendly Fluorescence with control SparkControl Brightfield and FU

  14. Slide 14: Vascular leakage assessment

    Vascular leakage assessment Dextran is retained in the TRITC-Dextran blood vessel lumen but permeates in the adjacent Snake venom Fluorescence intensity channel if the barrier is Vascular leakage measurement disrupted 25000 Venom 1 20000 D e x t r a n - S ig n a l 15000 Venom 2 Time 10000 Venom 3 50

  15. Slide 15: Dead nuclei count

    Dead nuclei count TRITC-Dextran Snake venom DRAQ7 Imaging Dead nuclei count 50 t = 1 m in 50 t = 2 5 m in 50 t = 5 0 m in 50 t = 1 5 0 m in 40 40 40 40 # D e a d c e lls # D e a d c e lls # D e a d c e lls # D e a d c e lls 30 30 30 30 20 20 20 20 10 10 10 10 1% Triton control (100% dead cells) 0 0

  16. Slide 16: Viability assessment

    Viability assessment Fluorescence intensity measurement Viability / morphology TRITC-Dextran Calcein-AM Snake venom DRAQ7 150 t = 5 0 m in 400 100 % V ia b ility 300 % V ia b ility 200 50 100 0 0 0 10 20 30 40 50 d 1 2 3 4 te T im e (m in ) m m m m a o o o o e n n n n tr e e e e n V V V V U After 50

  17. Slide 17: Morphological assessment

    Morphological assessment 400 300 Imaging Morphology % V ia b ility 200 100 0 0 10 20 30 40 50 T im e (m in ) Venom 2 The action of the venom does not cause the cells to die but rather to contract, hence an increase in signal is measured. Subsequently, the integrity of the whole structure is compromi

  18. Slide 18: Summary

    Summary Circulatory system Venom 1 No apparent cell necrosis but massive blood vessel structure damage and high blood vessel barrier disruption Venom 2 Venom 3 Indication of endothelial cell necrosis and elevated blood vessel leakage Venom 4 Slight indication of endothelial cell necrosis but no clea

  19. Slide 19: Conclusion

    Conclusion • Increasing importance of in vitro pre-clinical test platforms • Complex organ-on-chip models are used to perform functional assessment of bioactive substances, such as snake venoms • This requires appropriate, automation capable and relevant 3D organ-on-chip models • This also requires

  20. Slide 20: Contributors

    Contributors Flavio Bonanini1, Mátyás Bittenbinder2,3,4, Jeroen Kool3,4, Freek J. Vonk2,3,4, Sebastiaan J. Trietsch1, Dorota Kurek1 1 Mimetas, Leiden, The Netherlands 2 Naturalis Biodiversity Center, 2333 CR Leiden, The Netherlands 3 Amsterdam Institute of Molecular and Life Sciences, Division of Bi

Mimetas — Technical Presentation (2023) on 6ix